ArticleJournal of clinical medicine2024

Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients.

Lutz Liefeldt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.